Cue Biopharma Secures $50M Private Placement: What it Means for Biotech ETFs

Cue Biopharma, a clinical-stage biopharmaceutical company, has successfully completed a $50 million private placement. This capital infusion, announced on July 10, 2026, provides the company with significant funding, a move that could stabilize its financial…